Search Area
Info-Center
Besuchen Sie eticur) auf Ihrem Lieblingsnetzwerk:
Professional competence and a lot of experience
Our team of experts
Your aptitude for donation is assessed by a medical expert team. To a large extent, this ensures that there are no medical obstacles for a successful umbilical cord blood stem cell collection and storage. In order to carry out the assessment, the filled out anamnesis form and the medical findings of the gynaecologist are taken into account. The expert team consists of experienced doctors in the field of stem cell processing and paediatrics. The director of processing at eticur), Mr Dr. med. Josef Frank, and the head doctor for the placenta blood bank of the Friedrich-Alexander-University Erlangen, Professor Dr. med. Volker Weisbach.
Dipl. Biologin Kathrin Floegel
is the quality director at eticur). The biologist has long-term practical experience in the seperation of cord blood stemcells. Moreover she has experience in the field of cell culture and quality management.
Kathrin Floegel: "Apart from the so far known areas of application for blood stem cells from umbilical cord blood, also many areas of application in the field of regenerative medicine are expected in future. Further cell populations of the umbilical cord are momentarily intensively examined for possible therapeutical use”.
Prof. Dr. med. Volker Weisbach
is head doctor at the transfusion medical and haemostaseologic department (director: Professor Dr. med. Reinhold Eckstein) of the University Hospital Erlangen and responsible for the placenta blood bank. Professor Dr. Weisbach has already been examining the use of stem cells for many years. Moreover, he has improved the storage and examination of the cells with his colleagues and set the benchmark on the highest level.
Professor Dr. med. Weisbach: "New research results give cause for hope that in future, stem cells from umbilical cord blood will play an important role in the field of cell- and tissue replacement with acute or chronic diseases. From these stem cells, many different cells of various organ systems of the human body can be produced in the laboratory. Animal experiments already showed that the therapeutical use of stem cells from umbilical cord blood have promising results. I presume that a large number of new, reasonable and successful treatments will originate from these cells and therefore all donors of umbilical cord blood will be able to profit."
Dr. med. Josef Frank
is director of the department for children´s cardiology and paediatric intensive medicine in the Klinikum Großhadern and the children´s hospital Dr. von Haunerschen Kinderspital of the Ludwig-Maximilians-University Munich. In his department, any not-invasive, invasive and operative examination- and treatment measures for heart diseases with children. Moreover, Großhadern is the only medical centre in the field of cardiac- and cardio-pulmonal transplantation for infants and children with an extensive experience in Bavaria and is therefore one of the few transplantation centres for children in Germany.
Dr. med. Josef Frank: "For many infants and children with congenital heart defects or who acquired these defects after birth, a treatment would be far easier when autologous (own) material for replacement would be at hand. For example: cardiac valve defects or defects of the cardiac septum. I expect that in future it will be possible to create such tissues from umbilical cord blood stem cells. There has already been some progress with cardiac valves for children. Also when e.g. cells of the heart muscle are weakened by infections and die off, stem cells can help the heart muscle to recover and therefore a heart transplantation can be avoided. First studies with elder patients after heart attacks are also very promising".
© 2004-2012 eticur) GmbH, Am Klopferspitz 19, 82152 Martinsried, Tel. +49 (89) 125981-0
